<DOC>
	<DOCNO>NCT00327197</DOCNO>
	<brief_summary>To evaluate compare expression change expression key severe asthma target baseline mile moderate asthmatic vs. severe asthmatic subject . To evaluate compare airway pathology baseline change airway pathology relation asthma severity .</brief_summary>
	<brief_title>Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Inclusion criterion : History asthma exclusion significant pulmonary disease . Body Mass Index 1931 kg.m2 . Subjects assign group 1 ( mild moderate ) Group 2 ( severe asthmatic ) depend Lung Function test result . Exclusion criterion : As result medical interview , physical examination screen investigation physician responsible considers subject unfit study . History drug allergy , , opinion responsible physician , contraindicate participation . Subject female pregnant lactating . Currently plan take study regular medication ( include overthecounter ) except medication allow inclusion criterion . Having participate within 30 day 5 halflives , whichever long first dose study use new molecular entity , first dose study investigate drug participate within one month first dose study invasive procedure . History current evidence upper low respiratory infection symptom ( include common cold ) within 2 week baseline assessment . History abnormal bruising bleeding . History alcohol drug abuse . Doing nightshift work within least 5 day prior dose completion study . Anticoagulants except low dose Aspirin ( 80 mg per day ) ( bronchoscopy ) . Beta blocker except low dose Atenolol ( 25 mg/day ) Metoprolol ( 50 mg/day ) ( bronchoscopy ) . Use Cytochrome P450 inhibitor . History hypersensitivity follow medication : Lidocaine , Fentanyl , Versed , Demerol , Midazolam , Epinephrine , Flumazenil Naloxone . History hypersensitivity bronchodilator ( Albuterol ) . In addition , follow additional exclusion criterion must apply mild moderate persistent asthmatic regular inhaled steroid : Changed asthma medication within 4 week prior screen . Has asthma exacerbation previous month . Known sensitivity allergy prednisolone . Current use use within previous 3 month oral corticosteroid . Current use Methotrexate , cyclosporine PDE inhibitor History tuberculosis , diabetes mellitus , osteoporosis , severe hypertension , glaucoma , severe affective disorder peptic ulceration . In addition , follow additional exclusion criterion must apply severe persistent asthmatic clinical control asthma symptom : Changed asthma medication within 4 week prior screen . Has asthma exacerbation previous month . sensitivity allergy prednisolone . History tuberculosis , diabetes mellitus , osteoporosis , hypertension , glaucoma , severe affective disorder peptic ulceration . Current use use within previous 4 week oral prednisolone equivalent great 20mg daily . Current use Methotrexate , cyclosporin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>bronchoscopy</keyword>
	<keyword>Sputum induction</keyword>
	<keyword>Prednisolone</keyword>
	<keyword>Asthma</keyword>
	<keyword>biomarkers</keyword>
</DOC>